샘플 요청 목록

 카트 문의
시장보고서
상품코드
1794514

세계의 무바늘 당뇨병 치료 시장

Needle Free Diabetes Care
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 284 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 무바늘 당뇨병 치료 시장은 2030년까지 168억 달러에 달할 전망

2024년에 131억 달러로 추정되는 세계의 무바늘 당뇨병 치료 시장은 분석 기간인 2024-2030년에 CAGR 4.2%로 성장하며, 2030년에는 168억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 인슐린 주입기는 CAGR 3.2%를 기록하며, 분석 기간 종료시에는 56억 달러에 달할 것으로 예상됩니다. 인슐린 패치 부문의 성장률은 분석 기간에 CAGR 5.2%로 추정됩니다.

미국 시장은 36억 달러로 추정, 중국은 CAGR 7.5%로 성장 예측

미국의 무바늘 당뇨병 치료 시장은 2024년에 36억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 34억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 7.5%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.8%와 3.2%로 예측됩니다. 유럽에서는 독일이 CAGR 2.5%로 성장할 것으로 예측됩니다.

세계의 바늘 없음 당뇨병 케어 시장 - 주요 동향과 촉진요인 정리

무바늘 당뇨병 치료가 만성질환 관리에서 주목받는 이유는 무엇인가?

무바늘 당뇨병 관리 기술은 기존의 바늘을 이용한 포도당 모니터링과 인슐린 투여에 따른 불편함, 불편함, 위험에 대처하기 위해 개발 및 채택되고 있습니다. 많은 환자들에게 반복적으로 손가락을 찌르거나 인슐린을 주사하는 것은 통증, 피부 염증, 불안을 유발하고 치료 순응도에 영향을 미칠 수 있습니다. 무바늘 시스템은 통증이 없고, 사용하기 쉽고, 비침습적 또는 최소 침습적 대안을 제공함으로써 환자의 순응도를 향상시키는 것을 목표로 합니다.

이러한 기술에는 경피 패치, 제트 인젝터, 레이저 기반 장치, 마이크로니들 어레이, 간질액, 땀, 빛 신호를 이용하는 비침습적 포도당 모니터 등이 있습니다. 웨어러블 지속혈당측정기(CGM)와 스마트 센서가 수동 모니터링 방식을 대체하고 있습니다. 인슐린 투여와 모니터링 기능을 통합한 장치도 등장하여 보다 정확하고 개인화된 혈당 조절을 가능하게 하고 있습니다. 삶의 질(QOL)과 장기적인 질병 자가 관리에 대한 관심이 높아지면서 이러한 혁신적인 툴에 대한 관심이 높아지고 있습니다.

새로운 기술은 어떻게 접근성과 효율성을 높이고 있는가?

바이오센서 기술, 소형화, 무선통신의 발달로 보다 정확하고 반응성이 높은 무침 솔루션의 개발이 촉진되고 있습니다. 피부 센서를 사용하는 CGM은 현재 스마트폰이나 인슐린 펌프에 실시간으로 데이터를 전송하여 물리적 중단 없이 지속적인 추적을 가능하게 합니다. 주사바늘을 사용하지 않고 고압의 유로를 통해 인슐린을 투여하는 제트 인젝터는 투여 정확도 향상과 조직 외상 감소를 위해 개선되고 있습니다.

광학 신호, 전자기 신호, 초음파 신호를 이용한 비침습적 혈당 모니터링 장치가 활발히 연구되고 있지만, 신뢰할 수 있는 정확도를 달성하는 것은 여전히 과제입니다. 디지털 헬스 플랫폼은 의료 서비스 프로바이더의 원격 모니터링과 더 넓은 만성질환 관리 생태계에 통합될 수 있도록 이들 기기와 연동되고 있습니다. 배터리 효율성, 사용자 인터페이스 디자인, 데이터 시각화 툴은 일상적인 사용 편의성과 광범위한 보급을 지원하기 위해 개선되고 있습니다.

어떤 최종사용자와 케어 모델이 바늘 없는 솔루션에 대한 수요를 주도하고 있는가?

바늘 없는 당뇨병 장치의 주요 사용자는 편안함, 편의성, 치료 순응도를 높이고자 하는 제1형 및 2형 당뇨병 환자들을 포함합니다. 소아 환자, 노인, 바늘 공포증 환자는 특히 비침습적 옵션의 혜택을 받을 가능성이 높습니다. 재택 및 원격 진료 모델은 통제력을 유지하면서 병원 방문을 최소화하는 자가 조작 및 웨어러블 솔루션에 대한 수요 증가에 기여하고 있습니다.

의료진과 당뇨병 교육자들도 환자 관리 계획에 무바늘 장치를 도입하여 환자와의 관계를 개선하고 합병증을 줄이는 데 도움을 주고 있습니다. 약국, 원격의료 플랫폼, 보험사들은 맞춤형 의료 계획의 일환으로 이러한 기기를 지원하기 시작했습니다. 당뇨병 유병률이 높고 임상 인프라가 제한된 지역에서 무침 기술은 기존 의료 시스템의 부담을 줄일 수 있는 확장 가능한 대안을 제공합니다.

바늘없는 당뇨병 치료 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다.

바늘 없는 당뇨병 치료 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 전 세계에서 당뇨병 유병률이 증가함에 따라 더 나은 환자 친화적인 관리 툴이 요구되고 있습니다. 센서 기술, 웨어러블 일렉트로닉스, 무선 데이터 통합의 발전은 기기의 성능과 사용자 경험을 향상시킵니다. 자가 모니터링과 장기적인 질병 관리에 대한 인식이 높아짐에 따라 소비자의 채택을 촉진합니다. 디지털 헬스 생태계의 확장은 무침 장치와 모바일 앱 및 클라우드 플랫폼의 통합을 촉진합니다. 소아 및 노인의료 모델에서는 안전성과 순응도를 향상시키는 무통 솔루션이 선호되고 있습니다. 규제 당국의 승인과 비침습적 진단에 대한 투자로 여러 지역에서 제품 개발 및 시장 개발이 가속화되고 있습니다.

부문

디바이스 유형(인슐린 주입기, 인슐린 패치, 인슐린 펜, 인슐린 펌프, 제트 인젝터), 최종사용자(홈케어 최종사용자, 진단 센터 최종사용자, 병원 & 클리닉 최종사용자)

조사 대상 기업의 예

  • 3M Company
  • Akeso/D. Medical Industries(Spring pump)
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Bioject Medical Technologies, Inc.
  • CeQur Corporation
  • Crossject SA
  • Echo Therapeutics Inc.
  • Endo International plc
  • European Pharma Group BV
  • Injex Pharma AG
  • Insulet Corporation(Omnipod)
  • Johnson & Johnson
  • MannKind Corporation
  • Medtronic PLC
  • NuGen Medical Devices(InsuJet)
  • Pancreum LLC
  • PharmaJet, Inc.
  • Tandem Diabetes Care, Inc.
  • Valeritas, Inc.
  • Zogenix, Inc.

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.28

Global Needle Free Diabetes Care Market to Reach US$16.8 Billion by 2030

The global market for Needle Free Diabetes Care estimated at US$13.1 Billion in the year 2024, is expected to reach US$16.8 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Insulin Infuser, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Insulin Patches segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 7.5% CAGR

The Needle Free Diabetes Care market in the U.S. is estimated at US$3.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Needle-Free Diabetes Care Market - Key Trends & Drivers Summarized

Why Is Needle-Free Diabetes Care Attracting Attention in Chronic Disease Management?

Needle-free diabetes care technologies are being developed and adopted to address the discomfort, inconvenience, and risks associated with traditional needle-based methods of glucose monitoring and insulin delivery. For many patients, repeated finger-pricking and insulin injections cause pain, skin irritation, and anxiety, which can impact adherence to treatment. Needle-free systems aim to improve patient compliance by offering painless, user-friendly, and non-invasive or minimally invasive alternatives.

These technologies include transdermal patches, jet injectors, laser-based devices, microneedle arrays, and non-invasive glucose monitors that use interstitial fluid, sweat, or optical signals. Wearable continuous glucose monitors (CGMs) and smart sensors are increasingly replacing manual monitoring. Devices that integrate insulin delivery with monitoring capabilities are also emerging, allowing for more precise and personalized glycemic control. The increasing emphasis on quality of life and long-term disease self-management is fueling interest in these innovative tools.

How Are Emerging Technologies Enhancing Accessibility and Efficiency?

Advancements in biosensor technology, miniaturization, and wireless communication are driving development of more accurate and responsive needle-free solutions. CGMs using skin sensors now transmit real-time data to smartphones or insulin pumps, enabling continuous tracking without physical disruption. Jet injectors, which deliver insulin through high-pressure streams without needles, are being refined to offer better dosing accuracy and reduced tissue trauma.

Non-invasive blood glucose monitoring devices using optical, electromagnetic, or ultrasound signals are under active research, although achieving reliable accuracy remains a challenge. Digital health platforms are increasingly linked with these devices, allowing remote monitoring by healthcare providers and integration into broader chronic care ecosystems. Battery efficiency, user interface design, and data visualization tools are being improved to support daily usability and broader adoption.

Which End-Users and Care Models Are Driving Demand for Needle-Free Solutions?

The primary users of needle-free diabetes devices include type 1 and type 2 diabetes patients seeking comfort, convenience, and better treatment adherence. Pediatric patients, elderly individuals, and needle-phobic users are particularly likely to benefit from non-invasive options. Home-based and remote care models are helping expand demand for self-operated and wearable solutions that minimize clinic visits while maintaining control.

Healthcare providers and diabetes educators are also incorporating needle-free devices into patient management plans to improve engagement and reduce complications. Pharmacies, telemedicine platforms, and insurance providers are beginning to support these devices as part of personalized health plans. In regions with high diabetes prevalence and limited clinical infrastructure, needle-free technologies offer scalable alternatives that reduce the burden on traditional healthcare systems.

Growth in the Needle-Free Diabetes Care Market Is Driven by Several Factors…

Growth in the needle-free diabetes care market is driven by several factors. Increasing diabetes prevalence worldwide demands better and more patient-friendly management tools. Advancements in sensor technology, wearable electronics, and wireless data integration improve device performance and user experience. Rising awareness of self-monitoring and long-term disease control supports consumer adoption. Expansion of digital health ecosystems encourages the integration of needle-free devices with mobile apps and cloud platforms. Pediatric and geriatric care models favor painless solutions that improve safety and compliance. Regulatory approvals and investment in non-invasive diagnostics are accelerating product development and market entry across multiple regions.

SCOPE OF STUDY:

The report analyzes the Needle Free Diabetes Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors); End-Use (Homecare End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • 3M Company
  • Akeso/D. Medical Industries (Spring pump)
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Bioject Medical Technologies, Inc.
  • CeQur Corporation
  • Crossject SA
  • Echo Therapeutics Inc.
  • Endo International plc
  • European Pharma Group BV
  • Injex Pharma AG
  • Insulet Corporation (Omnipod)
  • Johnson & Johnson
  • MannKind Corporation
  • Medtronic PLC
  • NuGen Medical Devices (InsuJet)
  • Pancreum LLC
  • PharmaJet, Inc.
  • Tandem Diabetes Care, Inc.
  • Valeritas, Inc.
  • Zogenix, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Needle Free Diabetes Care - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Discomfort With Traditional Injections Spurs Demand for Needle-Free Diabetes Management Solutions
    • Increased Adoption of Jet Injectors and Transdermal Delivery Systems Throws Spotlight on Pain-Free Alternatives
    • Rising Diabetes Prevalence Globally Strengthens Business Case for User-Friendly, Non-Invasive Technologies
    • OEM Innovation in Patch-Based and Microneedle-Free Insulin Delivery Enhances Convenience and Compliance
    • Advancements in Continuous Glucose Monitoring (CGM) and Non-Invasive Sensors Drive System Integration
    • Patient Preference for Less Intrusive, Home-Based Care Supports Transition to Needle-Free Devices
    • Technological Breakthroughs in Ultrasonic, Iontophoretic, and Laser-Based Insulin Delivery Propel Market Differentiation
    • Government Focus on Improving Diabetes Management Infrastructure Encourages Inclusion of New Delivery Options
    • Growing Pediatric and Geriatric Diabetic Population Fuels Need for Gentle and Easy-to-Use Delivery Methods
    • Expansion of Telemedicine and Remote Patient Monitoring Strengthens Use of Portable Needle-Free Devices
    • Shift Toward Wearable and App-Connected Devices Supports Adoption in Tech-Savvy Urban Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Needle Free Diabetes Care Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Needle Free Diabetes Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Insulin Infuser by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Insulin Infuser by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Insulin Infuser by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Insulin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Insulin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Insulin Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Insulin Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Insulin Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Insulin Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Insulin Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Homecare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Needle Free Diabetes Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Needle Free Diabetes Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Needle Free Diabetes Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Needle Free Diabetes Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Needle Free Diabetes Care by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Needle Free Diabetes Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Needle Free Diabetes Care by Device Type - Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Needle Free Diabetes Care by Device Type - Percentage Breakdown of Value Sales for Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps and Jet Injectors for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Needle Free Diabetes Care by End-Use - Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Needle Free Diabetes Care by End-Use - Percentage Breakdown of Value Sales for Homecare End-Use, Diagnostic Centers End-Use and Hospitals & Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제